These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19147585)

  • 1. Inhibition of peroxisome proliferator-activated receptor gamma increases estrogen receptor-dependent tumor specification.
    Yin Y; Yuan H; Zeng X; Kopelovich L; Glazer RI
    Cancer Res; 2009 Jan; 69(2):687-94. PubMed ID: 19147585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-targeted inhibition of peroxisome proliferator-activated receptor-gamma enhances the chemopreventive effect of anti-estrogen therapy.
    Yuan H; Kopelovich L; Yin Y; Lu J; Glazer RI
    Oncotarget; 2012 Mar; 3(3):345-56. PubMed ID: 22538444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis.
    Yin Y; Russell RG; Dettin LE; Bai R; Wei ZL; Kozikowski AP; Kopelovich L; Glazer RI
    Cancer Res; 2005 May; 65(9):3950-7. PubMed ID: 15867396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
    Zhang H; Kuang SQ; Liao L; Zhou S; Xu J
    Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of PPARγ expression in mammary secretory epithelial cells creates a pro-breast tumorigenic environment.
    Apostoli AJ; Skelhorne-Gross GE; Rubino RE; Peterson NT; Di Lena MA; Schneider MM; SenGupta SK; Nicol CJ
    Int J Cancer; 2014 Mar; 134(5):1055-66. PubMed ID: 23934545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors.
    Zhang C; Mori M; Gao S; Li A; Hoshino I; Aupperlee MD; Haslam SZ; Xiao H
    Cancer Res; 2010 Dec; 70(24):10224-33. PubMed ID: 21159643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
    Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
    Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis.
    Patel Y; Soni M; Awgulewitsch A; Kern MJ; Liu S; Shah N; Singh UP; Chen H
    Oncogene; 2019 Jan; 38(3):445-453. PubMed ID: 30104710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
    Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
    Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARδ induces estrogen receptor-positive mammary neoplasia through an inflammatory and metabolic phenotype linked to mTOR activation.
    Yuan H; Lu J; Xiao J; Upadhyay G; Umans R; Kallakury B; Yin Y; Fant ME; Kopelovich L; Glazer RI
    Cancer Res; 2013 Jul; 73(14):4349-61. PubMed ID: 23811944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of peroxisome proliferator-activated receptor gamma promotes tumorigenesis through activation of the beta-catenin / T cell factor (TCF) pathway in the mouse intestine.
    Fujisawa T; Sugiyama M; Tomimoto A; Wada K; Endo H; Takahashi H; Yoneda K; Yoneda M; Inamori M; Saito S; Terauchi Y; Kadowaki T; Tsuchiya N; Nakagama H; Nakajima A
    J Pharmacol Sci; 2008 Dec; 108(4):535-44. PubMed ID: 19075513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The meaning of non-classical estrogen receptors and peroxisome proliferator-activated receptor for boar Leydig cell of immature testis.
    Kotula-Balak M; Duliban M; Pawlicki P; Tuz R; Bilinska B; Płachno BJ; Arent ZJ; Krakowska I; Tarasiuk K
    Acta Histochem; 2020 Apr; 122(3):151526. PubMed ID: 32094002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of estrogen receptor-alpha into the tTA/TAg conditional mouse model precipitates the development of estrogen-responsive mammary adenocarcinoma.
    Tilli MT; Frech MS; Steed ME; Hruska KS; Johnson MD; Flaws JA; Furth PA
    Am J Pathol; 2003 Nov; 163(5):1713-9. PubMed ID: 14578170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin-interacting protein Kindlin-2 induces mammary tumors in transgenic mice.
    Li B; Chi X; Song J; Tang Y; Du J; He X; Sun X; Bi Z; Wang Y; Zhan J; Zhang H
    Sci China Life Sci; 2019 Feb; 62(2):225-234. PubMed ID: 30460471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caloric restriction inhibits mammary tumorigenesis in MMTV-ErbB2 transgenic mice through the suppression of ER and ErbB2 pathways and inhibition of epithelial cell stemness in premalignant mammary tissues.
    Ma Z; Parris AB; Howard EW; Shi Y; Yang S; Jiang Y; Kong L; Yang X
    Carcinogenesis; 2018 Oct; 39(10):1264-1273. PubMed ID: 30107476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming acidic coiled coil 1 promotes transformation and mammary tumorigenesis.
    Cully M; Shiu J; Piekorz RP; Muller WJ; Done SJ; Mak TW
    Cancer Res; 2005 Nov; 65(22):10363-70. PubMed ID: 16288026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.
    Bonofiglio D; Gabriele S; Aquila S; Catalano S; Gentile M; Middea E; Giordano F; Andò S
    Clin Cancer Res; 2005 Sep; 11(17):6139-47. PubMed ID: 16144913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary γ-Tocopherol-Rich Mixture Inhibits Estrogen-Induced Mammary Tumorigenesis by Modulating Estrogen Metabolism, Antioxidant Response, and PPARγ.
    Das Gupta S; Sae-tan S; Wahler J; So JY; Bak MJ; Cheng LC; Lee MJ; Lin Y; Shih WJ; Shull JD; Safe S; Yang CS; Suh N
    Cancer Prev Res (Phila); 2015 Sep; 8(9):807-16. PubMed ID: 26130252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing roles for mammary epithelial-specific PPARγ signaling and activation during breast tumour progression.
    Apostoli AJ; Roche JM; Schneider MM; SenGupta SK; Di Lena MA; Rubino RE; Peterson NT; Nicol CJ
    Mol Cancer; 2015 Apr; 14():85. PubMed ID: 25889730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.